MYX mayne pharma group limited

Ann: SUBA-Itraconazole NDA accepted for review by US FDA, page-3

  1. 7,300 Posts.
    lightbulb Created with Sketch. 449
    This is a significant developemeent ina significant market.
    MYX drug will have advantages
    and will sell v v well.
    I am thinking a s a pharma man .
    They will snatch major market share even above 50% in a short time due to better bioavailability.
    cheers
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.08
Change
0.010(0.20%)
Mkt cap ! $412.7M
Open High Low Value Volume
$5.05 $5.08 $5.02 $395.8K 78.38K

Buyers (Bids)

No. Vol. Price($)
1 1996 $5.05
 

Sellers (Offers)

Price($) Vol. No.
$5.08 3084 3
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.